Chappell Smith & Arden, P.A. News

Subscribe to Our Newsletter:

Select list(s) to subscribe to

By submitting this form, you are consenting to receive marketing emails from: Premier Legal Marketing, 310 Grant Street, Pittsburgh, PA, 15219, You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

CSA Day of Action Campaign

September 17, 2020

Apply Below to Send a Tablet Chappell, Smith & Arden is proud to partner with the Injury Board in their Day of Action Campaign. Our goal is to help South Carolina nursing home residents stay in regular contact with their families during this unprecedented pandemic. Chappell, Smith & Arden’s campaign will be focused on providing…


Talcum Powder Case Update – August 2020

August 27, 2020

The talcum powder cases against Johnson & Johnson continue to ramp up.  In New Jersey, both the state court cases and the MDL have seen some movement over the last few months.  In the State of New Jersey, the Superior Court overturned a prior grant of summary judgment in favor of Johnson & Johnson, finding…


3M Litigation Update

August 27, 2020

In our last update on the 3M Combat Earplugs litigation, we were waiting on Judge Rodgers’s ruling on the Defendant’s “federal contractor” defense. Well, recently the Judge issued her ruling, and we won the motion! This is great news all of the 170,000+ cases that have been filed. Had the 3M won the motion, all…


2021 Best Lawyers

August 20, 2020

Chappell Smith & Arden, P.A. is pleased to announce that attorney Graham Newman was recently selected by his peers for inclusion in the 27th Edition of The Best Lawyers in America© for his work in Personal Injury Litigation – Plaintiffs and Product Liability Litigation – Plaintiffs. Graham also received the Best Lawyers® 2021 Product Liability…


Cancer as a Result of Using Zantac

April 14, 2020

Chappell, Smith & Arden, PA is actively pursuing cases on behalf of clients who may have contracted cancer as a result of using Zantac. On April 1, 2020, the Food and Drug Administration announced an immediate recall of all prescription and over the counter medications containing ranitidine, the active ingredient in Zantac. According to scientific…